Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States
Go back to Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 39.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.19 | 52 Week High | $66.55 | |||
| Open | $39.19 | 52 Week Low | $37.82 | |||
| Day High | $39.19 | P/E | N/A | |||
| Day Low | $39.19 | EPS | $0.00 | |||
| Volume | 41 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 39.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.19 | 52 Week High | $66.55 | |||
| Open | $39.19 | 52 Week Low | $37.82 | |||
| Day High | $39.19 | P/E | N/A | |||
| Day Low | $39.19 | EPS | $0.00 | |||
| Volume | 41 | |||||
